The Extended Surgical Concepts for Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Extended Surgical Concepts for Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors
Authors
Keywords
-
Journal
Journal of Hepatocellular Carcinoma
Volume Volume 10, Issue -, Pages 1873-1880
Publisher
Informa UK Limited
Online
2023-10-24
DOI
10.2147/jhc.s433598
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prioritized Requirements for First-Line Systemic Therapy for Hepatocellular Carcinoma: Broad Benefit with Less Toxicity
- (2023) Masatoshi Kudo Liver Cancer
- Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma
- (2022) Andrew X. Zhu et al. NATURE MEDICINE
- Atezolizumab plus Bevacizumab Followed by Curative Conversion (ABC Conversion) in Patients with Unresectable, TACE-unsuitable Intermediate-stage Hepatocellular Carcinoma
- (2022) Masatoshi Kudo Liver Cancer
- Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma
- (2022) Philipp K. Haber et al. GASTROENTEROLOGY
- A proposal for T1 subclassification in hepatocellular carcinoma: reappraisal of the AJCC 8th edition
- (2022) Chao-Wei Lee et al. Hepatology International
- Hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Disease Primers
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma
- (2021) Ann-Lii Cheng et al. JOURNAL OF HEPATOLOGY
- Newly Developed Modified ALBI Grade Shows Better Prognostic and Predictive Value for Hepatocellular Carcinoma
- (2021) Masatoshi Kudo Liver Cancer
- Radical or Not-So-Radical Prostatectomy: Do Surgical Margins Matter?
- (2021) Ioanna Maria Grypari et al. Cancers
- BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
- (2021) Maria Reig et al. JOURNAL OF HEPATOLOGY
- A New Era in Systemic Therapy for Hepatocellular Carcinoma: Atezolizumab plus Bevacizumab Combination Therapy
- (2020) Masatoshi Kudo Liver Cancer
- Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study
- (2020) Michael S Lee et al. LANCET ONCOLOGY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion
- (2016) Takashi Kokudo et al. JOURNAL OF HEPATOLOGY
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma
- (2009) Jaw-Ching Wu et al. JOURNAL OF HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now